trending Market Intelligence /marketintelligence/en/news-insights/trending/OQgsG55f1OaDXPRItJ5Byg2 content esgSubNav
In This List

ReShape Lifesciences to be delisted from Nasdaq

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


ReShape Lifesciences to be delisted from Nasdaq

ReShape Lifesciences Inc. said Nasdaq has determined to delist the company's shares from the stock exchange Dec. 31.

The decision is based on ReShape Lifesciences' failure to regain compliance with the exchange's $1 minimum bid price requirement.

The San Clemente, Calif.-based medical device company also failed to inform the exchange of its intent to list additional shares, another listing requirement.

ReShape Lifesciences stocks will now trade on the OTC Markets under the symbol RSLS.